Built for the biology that does not fit static structure.
Peptone is focused on drugging intrinsically disordered proteins through measured ensemble biology and experimentally grounded computation.
Peptone combines computational biology, protein analytics, and translational laboratories in Bellinzona. The team spans structural biology, computation, and translational laboratory science, working across academic collaborators and an experienced advisory board.
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
The Bellinzona BSL-2 lab connects expression, purification, characterization, and assay workflows for translational preclinical work.
Our backers saw what we saw: the proteins medicine called undruggable were never impossible, only unmeasured.
F-Prime Capital, Bessemer Venture Partners, Hoxton Ventures and Walden Catalyst joined us at the point where physics becomes biology — to turn a class of targets others avoided into a category we intend to define.
Disordered proteins matter in biology but lack a constant binding pocket. Peptone's platform pairs the accuracy of experiment with the efficiency of in-silico modeling to unlock these targets.
We had studied ML-based drug discovery for years, and Peptone's approach immediately stood out — a computational-physics platform uniquely suited to the structural dynamics of these difficult-to-drug proteins.
Kamil and Matt are mission-driven founders who have made this problem their life's work. We see in them the potential to build a category-defining company for drug development.
Backed by
